|
C5ORF34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.961100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.480100E-02 |
| Normal-vs-Stage2 |
6.043600E-02 |
| Normal-vs-Stage3 |
1.717860E-02 |
| Normal-vs-Stage4 |
1.265020E-01 |
| Stage1-vs-Stage2 |
2.388600E-01 |
| Stage1-vs-Stage3 |
2.370000E-01 |
| Stage1-vs-Stage4 |
3.363800E-01 |
| Stage2-vs-Stage3 |
8.967000E-01 |
| Stage2-vs-Stage4 |
7.075000E-01 |
| Stage3-vs-Stage4 |
5.778800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.996700E-04 |
| Normal-vs-AfricanAmerican |
3.279700E-02 |
| Normal-vs-Asian |
9.577300E-03 |
| Caucasian-vs-AfricanAmerican |
4.873800E-01 |
| Caucasian-vs-Asian |
5.251000E-01 |
| AfricanAmerican-vs-Asian |
3.261000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.118610E-03 |
| Normal-vs-Female |
2.404800E-03 |
| Male-vs-Female |
6.245200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.728100E-02 |
| Normal-vs-Extreme_Weight |
1.530260E-02 |
| Normal-vs-Obese |
4.379700E-03 |
| Normal-vs-Extreme_Obese |
7.275400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.598200E-01 |
| Normal_Weight-vs-Obese |
5.680600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.963390E-01 |
| Extreme_Weight-vs-Obese |
5.302000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.559190E-01 |
| Obese-vs-Extreme_Obese |
8.472400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.403300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.029000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.377840E-02 |
| Normal-vs-Age(81-100Yrs) |
3.797200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.158400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.167600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.361700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.645600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.380400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.814000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.375100E-04 |
| Normal-VS-Type2 PRCC |
4.454400E-01 |
| Normal-VS-KIRP CIMP |
1.370010E-02 |
| Normal-VS-Unclassified PRCC |
4.902800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.059600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.023440E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.819800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.737300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.020300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.179190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.111600E-01 |
| Normal-vs-N1 |
3.956600E-03 |
| Normal-vs-N2 |
2.761400E-01 |
| N0-vs-N1 |
1.441620E-02 |
| N0-vs-N2 |
6.572600E-01 |
| N1-vs-N2 |
3.886200E-01 |
|
|
